The FDA Group's Insider Newsletter

The FDA Group's Insider Newsletter

Share this post

The FDA Group's Insider Newsletter
The FDA Group's Insider Newsletter
FDA Guidance Breakdown: Quality Considerations for Topical Ophthalmic Drug Products (Updated for December 2023 Revision)
Copy link
Facebook
Email
Notes
More

FDA Guidance Breakdown: Quality…

The FDA Group
Oct 17, 2023
3

Share this post

The FDA Group's Insider Newsletter
The FDA Group's Insider Newsletter
FDA Guidance Breakdown: Quality Considerations for Topical Ophthalmic Drug Products (Updated for December 2023 Revision)
Copy link
Facebook
Email
Notes
More

The guidance discusses certain quality considerations for ophthalmic drug products (i.e., solutions, suspensions, emulsions, gels, ointments, and creams) intended for topical eye delivery.

Read →
Comments
User's avatar
© 2025 The FDA Group, LLC
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More